ArticleFrontiers in immunology2022

Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects.

Tanuja Chitnis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.